Skip to search formSkip to main contentSkip to account menu

Tarceva

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Erlotinib Hydrochlorideerlotinib
erlotinib 100 MG Oral Tablet [Tarceva]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Skin rash in patients treated with neoadjuvant erlotinib (Tarceva) in resectable non-small cell lung cancer: Predictor for tumor response and survival?
Background: Skin rash during treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKI) has been… 
2016
2016
Avastin in combination with Tarceva for patients with a specific type of advanced lung cancer
  • 2016
  • Corpus ID: 49583685
The pivotal phase II JO25567 study showed a statistically significant 46 percent relative reduction in the risk of disease… 
2012
2012
Abstract 2343: Establishment of patients’ primary non-small cell lung cancer xenograft models for test of anticancer drugs
BACKGROUND Human xenograft tumor models established by transplantation of human tumor cell lines into immunodifficient mice have… 
2009
2009
Clinical study of tarceva in combination with Xiaoyantang plus-minus prescriptions in treatment of non-small cell lung cancer
Objective:To observe tarceva combined with xiaoyantang plus-minus prescriptions in treatment of non-small cell lung cancer… 
2009
2009
Avastin-Tarceva combination fails in lung cancer
2008
2008
A phase I study of PEG-intron, sunitinib and tarceva in patients with metastatic renal cell cancer (MRCC)
14659 Background: Renal cell cancer (RCC) frequently overexpresses basic vascular endothelial growth factor, epithelial growth… 
2008
2008
Erlotinib (tarceva) for non small cell lung cancer
2007
2007
[Erlotinib (Tarceva) induced severe exanthema].
2006
2006
Observation of Erlotinib (Tarceva) combined with gemcitabine in advanced pancreatic adenocarcinoma
  • Li We
  • 2006
  • Corpus ID: 76007457
Objective:To evaluate the efficacy,clinical benefitial response(CBR),and toxicity of Tarceva combined with gemcitabine in… 
2005
2005
Erlotinib (Tarceva) for advanced non-small cell lung cancer.
Erlotinib (Tarceva) is the second oral epidermal growth factor receptor (EGFR) inhibitor to become available in the US for…